Clinical trial Recruiting at 2 sites Interventional Ages 18 to 90

Learning bimanual motor skills using robotics for stroke survivors and healthy individuals

Official title: Bimanual Motor Skill Learning Through Robotics in Stroke Survivors and Healthy Individuals

Run by University Hospital of Mont-Godinne · NCT03974750 · Data updated 2026-11-12

This study tests whether stroke survivors can learn and remember a complex motor skill using a special robot, and compares their progress to healthy individuals.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital of Mont-Godinne
Academic / other
Locations2 sites (Yvoir, Namur and 1 other locations)
StatusRecruiting
StartedJuly 1, 2017
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedApril 3, 2025
Trial IDNCT03974750 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include chronic stroke patients aged 18-90 years with a documented stroke lesion and healthy individuals within the same age range.

Probably not a fit

Patients with complete paralysis of the affected arm or severe cognitive deficits that interfere with understanding commands may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the ability of chronic stroke patients and healthy individuals to learn and retain a complex bimanual motor skill using the neurorehabilitation robot REAplan(R). Participants will undergo training over three consecutive days, performing both unimanual and bimanual tasks on the robot. Additionally, various clinical scales and tests will be employed to assess overall motor, sensory, and cognitive functions. The goal is to understand the differences in motor skill learning between stroke survivors and healthy individuals.

Why it matters

Potential benefit: If successful, this study could enhance rehabilitation strategies for stroke survivors, improving their motor skills and overall quality of life.

How similar studies have gone: Other studies have shown promise in using robotic rehabilitation for motor skill learning, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
STROKE PATIENTS :

Inclusion Criteria:

* having a chronic stroke (\>6 months)
* aged 18-90 years
* with demonstrate a stroke lesion on brain imaging.

Exclusion Criteria:

* difficulty in understanding or executing commands
* drug/alcohol abuse
* severe aphasia / cognitive deficits interfering with study
* inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
* multiple strokes / dementia / psychiatric condition
* botulinum toxin injections (to be evaluated)

HEALTHY INDIVIDUALS :

Inclusion Criteria:

\- 18-90 years

Exclusion Criteria:

* neurological conditions interfering with the study
* drug/alcohol abuse
* pyschiatric condition

Where it's running

  • CHU UCL Namur, Mont-Godinne, Neurology Department, Stroke Unit
    Yvoir, Namur, Belgium
    Recruiting
  • Department of Neurology, CHU Mont-Godinne
    Yvoir, Namur, Belgium
    Recruiting

Study contacts

  • Principal investigator: Yves Y Vandermeeren, MD, PhD — Université catholique de Louvain, Institute of NeuroScience (IONS) NEUR / CHU
  • Study coordinator: Yves Vandermeeren, MD, PhD
  • Email: yves.vandermeeren@uclouvain.be
  • Phone: +3281423321

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.